- Aduhelm’s label is backtracked and investigations into its approval launched
- A “New Era” UK MHRA shares delivery plan for 2021-2023
- Biden signs executive order impacting prescription drug pricing
- NICE to publish guidance for treatment of blood clots associate with COVID-19 vaccines